The effect of Oxytocin on the duration of third stage of labor

Assessment the effect of intraumbilical vein Oxytocin injection in comparison to normal saline on third stage of labor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017052810340N15

Enrollment

Registered

2017-06-29

Start date

2017-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

duration of labor. Pregnancy, childbirth and the puerperium

Interventions

Intervention 1: Control group will receive 20ml of normal saline by injection into the intraumblical vein. Intervention 2: Intervention group will receive 30 units of oxytocin, dissolved in 17 ml of n

Placebo

Treatment - Drugs

Control group will receive 20ml of normal saline by injection into the intraumblical vein.

Intervention group will receive 30 units of oxytocin, dissolved in 17 ml of normal saline, by injection into the intraumbilical vein

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: First pregnancy; singleton pregnancy; gestational age term (over 37 weeks); signs of labor ( regular contractions with the appropriate power 3 per 10 minutes); cephalic presentation. Exclusion criteria were considered as: Multi gravity; polyhydramnios; severe anemia; uterine scar; the use of forceps or vacuum; placenta previa; prolonged labor (over 20 hours); bleeding before delivery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Duration of third stage of labor. Timepoint: After intervention. Method of measurement: Stopwatch.	—

Secondary

Measure	Time frame
Hemoglobin. Timepoint: After intervention. Method of measurement: Blood sample.;Hematocrit. Timepoint: After intervention. Method of measurement: Blood sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhazale Sadeghian

Golestan University of Medical Science

ghazalaljoon65@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026